4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-029618
Director sold 26,016 shares at $20.30 ($528,237)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2017-12-22 | Sale | −26,016 | $20.30 | $528,237 | 27,724 | D: show line 1 in the form |
| Open-market sales · 26,016 sh · avg $20.30 · $528,237 | |||||||
Loading xslF345X03/doc4.xml…